Top Marijuana Shares regarding the NASDAQ

Top Marijuana Shares regarding the NASDAQ

Even though the greater part of U.S.-based cannabis businesses and several foreign American Depository Receipts (ADRs) trade throughout the countertop (OTC), a marijuana that is few are traded regarding the NASDAQ. Some investors choose shares which are noted on the NASDAQ to many other exchanges for their increased liquidity and tighter spreads when compared to over-the-counter areas. For instance, due to the fact cannabis industry is continuing to grow in present months and years, uplisting from an OTC market to a professional U.S. trade is becoming a advertising achievement for all marijuana that is rising. (For associated reading, see “Understanding Medical Cannabis vs. Recreational Cannabis Stocks”)

An increasing wide range of cannabis businesses are now being noted on reputable U.S. exchanges as opposed to being exchanged in the OTC market showing the quick development of the cannabis industry.

NASDAQ-listed Marijuana shares

The NASDAQ ended up being the very first exchange that is electronic is certainly synonymous with technology and biotechnology. The cannabis organizations from the NASDAQ mirror this, in addition to majority of them run when you look at the biotech area of this industry. Here you will find the NASDAQ-listed marijuana shares, in alphabetical order, at the time of October 26, 2019, with a failure of these total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is really a biotech business mixed up in production of medical marijuana medications. Research and development around Arena’s APD371 may be the focus that is primary of company’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is really a check that is blank that is in a merger contract with Kalyx Development Inc. Kalyx is a number one investment rely upon the regulated cannabis industry in the us.

Key Takeaways

  • The cannabis industry, specially the part of cannabis and biotech, is attracting significant investor attention.
  • Cannabis has been utilized in brand new medications for the treating discomfort and chronic that is many inflammatory, and fibrotic conditions.
  • Organizations will also be developing cannabinoid items for autism range problems, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (a genetic condition), and addiction that is amphetamine.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is a clinical-stage biotechnology business focused on developing and commercializing new chemical entities when it comes to indications of discomfort and pruritus (itching). Although most of the company’s clinical-stage items target opioid receptors, Cara is currently performing preclinical research on cannabinoids to treat neuropathic pain.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech business. The team’s research, development, and production are based around cannabis drugs that look for to take care of chronic, inflammatory, fibrotic, along with other conditions.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is just A canadian cannabis business. The team owns and seeks cannabis-related subsidiaries and producers that are licensed. In December of 2018, Marlboro manufacturer Altria announced intends to invest $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to fund its continued expansion but in addition by having a partner that is well-established when you look at the advertising of customer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is a Boca Raton, Florida-based cannabis business. It distributes many different cannabis usage accessories and vaporization gear and items to customers that are retail the U.S. and Canada. Also, it runs websites that are e-commerce extra product sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is having a portfolio of cannabinoid medicines. These medications consist of Sativex for the treating spasticity associated with sclerosis that is multiple cancer tumors discomfort and Epidiolex for the treating youth epilepsy. Sativex is commercialized in more than the usual dozen nations outside the united states of america and contains gotten approval that is regulatory some other countries. Epidiolex received Food And Drug Administration approval being a treatment plan for Dravet Syndrome and Lennox-Gastaut Syndrome, two types of serious, very early beginning epilepsy without good current treatment plans. Other indications reveal that GW Pharmaceuticals is developing products that are cannabinoid autism range problems, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is really a clinical-stage biopharmaceutical business that is developing drugs according to its proprietary Accordion Pill technology. Intec’s product pipeline includes cannabinoid-based medications for lower back pain and fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally responsible bio-based pest administration and plant wellness items. In 2017, Marrone Bio Innovations announced that three MBII ingredients that are active now appropriate for usage on cannabis plants into the Ca cultivation market.

Modern Age Beverages Corp. (NASDAQ:NBEV)

Modern age Beverages Corp. is a maker of beverages produced from yerba mate, green tea extract, kombucha, and comparable services and products. In current months, New Age has expanded its beverage offerings to add CBD infusions also, bringing it in to the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted from the NASDAQ in might of 2019, which makes it probably one of the most current cannabis organizations to record from the popular trade. The organization happens to be rapidly expanding its production capability and could have the ability to create just as much as 113,000 kilograms of product per 12 months by the end of 2019.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation operates when you look at the enforcement sector. The business’s business operations support drug screening through hair examples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is yet another brand new entry on the NASDAQ trade. The cannabis producer made headlines in October of 2019 (and saw a price that is brief) whenever it announced the production of a fresh Palmetto model of leisure cannabis, first for sale in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is just a specialty clinical-stage company that is pharmaceutical in the growth of cannabinoid-based medications. Therapix’s present pipeline includes services and products targeted to treat Tourette problem and mild intellectual disability.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. ended up being the very first company that is marijuana-related have a short public offering (IPO) what is cbd oil in the United States. The Nanaimo, Vancouver Island-based company concentrates on medical cannabis services and products.

Village Farms Global (NASDAQ:VFF)

Village Farms Global is considered the most current cannabis stock to begin dealing on the NASDAQ. The business’s shares became designed for trade on February 21, 2019. The organization includes a decades-long history in greenhouse produce manufacturing and has now only recently shifted a number of its focus toward cannabis production.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted in the growth of artificial treatments that are cannabinoid transdermal (through your skin) distribution. Their pipeline currently includes two drugs being developed for indications including epilepsy, osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.